- Home
- KKR vs BMY Comparison
KKR vs BMY Comparison
Compare KKR & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KKR
- BMY
- Stock Information
- Founded
- KKR 1976
- BMY 1887
- Country
- KKR United States
- BMY United States
- Employees
- KKR N/A
- BMY N/A
- Industry
- KKR Investment Managers
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- KKR Finance
- BMY Health Care
- Exchange
- KKR Nasdaq
- BMY Nasdaq
- Market Cap
- KKR 101.3B
- BMY 120.5B
- IPO Year
- KKR 2010
- BMY N/A
- Fundamental
- Price
- KKR $115.60
- BMY $60.99
- Analyst Decision
- KKR Strong Buy
- BMY Hold
- Analyst Count
- KKR 14
- BMY 14
- Target Price
- KKR $160.79
- BMY $58.00
- AVG Volume (30 Days)
- KKR 7.0M
- BMY 12.4M
- Earning Date
- KKR 04-30-2025
- BMY 04-24-2025
- Dividend Yield
- KKR 0.61%
- BMY 4.07%
- EPS Growth
- KKR N/A
- BMY N/A
- EPS
- KKR 3.28
- BMY N/A
- Revenue
- KKR $26,421,798,000.00
- BMY $48,300,000,000.00
- Revenue This Year
- KKR N/A
- BMY N/A
- Revenue Next Year
- KKR $20.92
- BMY N/A
- P/E Ratio
- KKR $35.25
- BMY N/A
- Revenue Growth
- KKR 41.57
- BMY 7.32
- 52 Week Low
- KKR $91.92
- BMY $39.35
- 52 Week High
- KKR $170.40
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- KKR 40.32
- BMY 57.32
- Support Level
- KKR $113.82
- BMY $58.23
- Resistance Level
- KKR $123.48
- BMY $61.49
- Average True Range (ATR)
- KKR 4.35
- BMY 1.40
- MACD
- KKR 1.26
- BMY -0.11
- Stochastic Oscillator
- KKR 50.44
- BMY 80.94
About KKR KKR & Co. Inc.
KKR is one of the world's largest alternative asset managers, with $624.4 billion in total managed assets, including $505.7 billion in fee-earning AUM, at the end of September 2024. The company has two core segments: asset management (which includes private markets-private equity, credit, infrastructure, energy, and real estate-and public markets-primarily credit and hedge/investment fund platforms) and insurance (following the firm's initial investment in, and then ultimate purchase of, Global Atlantic Financial Group, which is engaged in retirement/annuity and life insurance lines as well as reinsurance).
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.